Logo

Innovative Drugs to Restore Neurological Function

Search Btn
  • Home
  • About Us
    • About Us
    • Management
    • Scientific Advisory Board
    • Board of Advisors
  • Disease Focus
    • Technology
    • Spinal Cord Injury
    • Cerebral Vascular Disorder
  • Patients
    • Patients
  • News
  • Contact Us
    • Contact Us

Ron Goldstein Picture

News

December 16, 2019: BioAxone BioSciences Expands Patent for Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors Receives Notice of Allowance on Patent Protection for Orally Available ROCK2 Inhibitor Click here for the full story .
September 12, 2019: BioAxone Announces Publication in Translational Stroke Research of Cavernous Angioma Disease Research Article. Click here for the full story.

Events

April 29, 2019. BioAxone’s CEO, Dr. Lisa McKerracher, will be a symposium speaker the the University of Toronto Department of Surgery 2nd Translational Research Workshop. iClick here.

© 2020 BioAxone | 763E Concord Avenue | Cambridge, Massachusetts 02138 | Ph: 617-401-3115 | Site by KWWD.co